TSX:APTX

Apotex Health Corp. · TSX · Healthcare · CAD · FY for 2026

Figures on this page computed 2026-11-08 13:25 UTC

Last close

n/aCAD

Market data

  • 21.4xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • computed
    • Computed from the filing for 2026
  • 19.4%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 10.7%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 13.2%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • computed

Follow one dollar

lens 1 of 9
After what it costs to make
55.6%
After running the business
22.5%
After interest and tax
10.7%
After what it must reinvest
13.2%
Kept after the dividend
-18.6%
after what it costs to make, 55.6% of sales; after running the business, 22.5% of sales; after interest and tax, 10.7% of sales; after what it must reinvest, 13.2% of sales; kept after the dividend, -18.6% of sales

The five stops

5 of 5 read
  • After what it costs to make1,941,630,00055.6%
  • After running the business786,223,00022.5%
  • After interest and tax373,776,00010.7%
  • After what it must reinvest458,983,00013.2%
  • Kept after the dividend-650,639,000-18.6%

Of every unit of sales, -0.19 is still there after the dividend.

Of every unit of sales, -0.19 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

  • Sales3,490,834,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CAD
  • After what it costs to make1,941,630,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CAD
  • After running the business786,223,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CAD
  • After interest and tax373,776,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CAD
  • After what it must reinvest458,983,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CAD
  • Kept after the dividend-650,639,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CAD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.